Seriously, this company is kicking goals. They have been able to demonstrate excellent PPL-1 results in both humans and canines in such a short time. As many have eluded, this is very early stage, however i have no doubt that PAA should be valued at closer to $50mill and not $12mill.
Stocks like NRT and PRR and many other oncology stocks are performing very well, despite being even earlier stage of having less potential. I've been saying it for months and months, but PAA will get the mother of all re-rates in due course. The trick is to know when...
I know i'll be hanging around because the upside is enormous. I wouldn't be surprised if PAA offered 10 x current levels in a very short time considering the potential of the assets they have.
Watch this space.
The Quiet Achiever, page-14
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.3¢ | 19.0¢ | $25.41K | 133.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5372 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 262575 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |